<description>&lt;p&gt;In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.&lt;/p&gt;</description>

Neurology Today in 5

American Academy of Neurology

Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke

FEB 5, 20264 MIN
Neurology Today in 5

Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke

FEB 5, 20264 MIN

Description

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.